Eltanexor
Eltanexor (KPT-8602) is a second-generation, highly specific and orally active exportin-1 (XPO1) inhibitor with potent anti-leukemic activity. Eltanexor (KPT-8602) inhibits XPO1-dependent nuclear export (EC50=60.9 nM) by directly targeting XPO1. Eltanexor (KPT-8602) induces Caspase-dependent apoptosis in a panel of leukemic cell lines[1].
Product Specifications
CAS Number
1642300-52-4
Product Name Alternative
KPT-8602
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
CRM1
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/KPT-8602.html
Purity
99.84
Solubility
DMSO : ≥ 100 mg/mL
Smiles
FC(F)(F)C1=CC(C(F)(F)F)=CC(C2=NN(/C=C(C3=CN=CN=C3)/C(N)=O)C=N2)=C1
Molecular Formula
C17H10F6N6O
Molecular Weight
428.29
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Arabis mosaic virus RNA2 polyprotein, partial
Recombinant Arabis mosaic virus RNA2 polyprotein, partial
Recombinant Arabis mosaic virus RNA2 polyprotein, partial
Recombinant Arabis mosaic virus RNA2 polyprotein, partial